BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9633289)

  • 1. Metastatic melanoma. The latest treatment options.
    Gale D
    Adv Nurse Pract; 1998 May; 6(5):42-6. PubMed ID: 9633289
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy in metastatic melanoma - still useful or out of date?
    Ugurel S
    Onkologie; 2011; 34(4):159-60. PubMed ID: 21447971
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical studies with sorafenib (Nexavar) in metastatic melanoma].
    Hauschild A
    J Dtsch Dermatol Ges; 2007 Apr; 5(4):345. PubMed ID: 17376105
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pilot study with vindesine as monotherapy in metastatic malignant melanomas].
    Balda BR; Jehn U; Klövekorn W; Wohlrab A
    MMW Munch Med Wochenschr; 1983 Jan; 125(3):54-6. PubMed ID: 6402675
    [No Abstract]   [Full Text] [Related]  

  • 5. New research advances for treating metastatic melanoma.
    Minutilli E
    Int J Dermatol; 2010 Jun; 49(6):712-4. PubMed ID: 20618481
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of extensive cutaneous metastatic melanoma with topical diphencyprone.
    Damian DL; Thompson JF
    J Am Acad Dermatol; 2007 May; 56(5):869-71. PubMed ID: 17276544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intralesional therapy of metastatic spreading melanoma with beta-interferon.
    Rapprich H; Hagedorn M
    J Dtsch Dermatol Ges; 2006 Sep; 4(9):743-6. PubMed ID: 16928243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective combined immunochemotherapy with dinitrochlorobenzene and fotemustine in skin and brain metastases of melanoma.
    Göring HD; Zierner A; Kröning Y; Trebing D; Kämpgen E; Bröcker EB
    Melanoma Res; 1998 Aug; 8(4):379. PubMed ID: 9764815
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic treatment of malignant melanoma.
    Mota A; Deisseroth A
    Clin Plast Surg; 2000 Jul; 27(3):463-74, x. PubMed ID: 10941566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Muscle metastasis of a coroid melanoma].
    Acebal R; Almodóvar R; Quirós FJ; Mazzuchelli R; Zarco P
    Reumatol Clin; 2011; 7(1):77-8. PubMed ID: 21794785
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of metastatic melanoma.
    Tawbi HA; Kirkwood JM
    Semin Oncol; 2007 Dec; 34(6):532-45. PubMed ID: 18083377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital malignant melanoma and cutaneous metastases treated with diphencyprone.
    Fawcett JM; Newell EL; Kennedy CT
    Clin Exp Dermatol; 2016 Mar; 41(2):212-3. PubMed ID: 26053880
    [No Abstract]   [Full Text] [Related]  

  • 13. Is isolated limb perfusion of metastatic malignant melanoma of the extremity worthwhile?
    Koops HS; Garbe C; Hohenberger P
    Eur J Cancer; 1996 Sep; 32A(10):1633-40. PubMed ID: 8983267
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of isolated limb perfusion to manage recurrent malignant melanoma.
    Ma D; Ariyan S
    Clin Plast Surg; 2000 Jul; 27(3):441-50, ix. PubMed ID: 10941564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II trial of arsenic trioxide in patients with metastatic melanoma.
    Kim KB; Bedikian AY; Camacho LH; Papadopoulos NE; McCullough C
    Cancer; 2005 Oct; 104(8):1687-92. PubMed ID: 16130126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Imiquimod for the treatment of skin metastases of melanoma].
    Nagore E; Botella-Estrada R; Sanmartín O; Guillén C
    Actas Dermosifiliogr; 2005 Oct; 96(8):549-50. PubMed ID: 16476296
    [No Abstract]   [Full Text] [Related]  

  • 17. Complete and long-lasting regression of disseminated multiple skin melanoma metastases under treatment with cyclooxygenase-2 inhibitor.
    Lejeune FJ; Monnier Y; Rüegg C
    Melanoma Res; 2006 Jun; 16(3):263-5. PubMed ID: 16718274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comments on the treatment of malignant melanoma].
    Zaumseil RP; Wohlrab W
    Dermatol Monatsschr; 1977 May; 163(5):367-71. PubMed ID: 881083
    [No Abstract]   [Full Text] [Related]  

  • 19. A phase II study of bortezomib in the treatment of metastatic malignant melanoma.
    Markovic SN; Geyer SM; Dawkins F; Sharfman W; Albertini M; Maples W; Fracasso PM; Fitch T; Lorusso P; Adjei AA; Erlichman C
    Cancer; 2005 Jun; 103(12):2584-9. PubMed ID: 15887220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy of melanoma].
    Bernheim JL; Kenis Y
    Acta Chir Belg; 1974 Mar; 73(2):249-63. PubMed ID: 4450922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.